 | 2008 |
|---|
| 8 |       | Silvana Penco,
Massimo Buscema,
Maria Cristina Patrosso,
Alessandro Marocchi,
Enzo Grossi:
New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.
BMC Bioinformatics 9: (2008) |
| 7 | | Massimo Buscema,
Enzo Grossi:
The semantic connectivity map: an adapting self-organising knowledge discovery method in data bases. Experience in gastro-oesophageal reflux disease.
IJDMB 2(4): 362-404 (2008) |
| 2007 |
|---|
| 6 | | Dirk Mayer,
Adam Maciak,
Thomas Rösler,
Tim Keszler,
Heiner Faber,
Massimo Buscema,
Marco Mattiuzzi,
T. W. Vomweg:
Vollautomatisierte Tumordiagnose in der dynamischen MRT der weiblichen Brust.
Bildverarbeitung für die Medizin 2007: 86-90 |
| 5 | | Massimo Buscema:
A novel adapting mapping method for emergent properties discovery in data bases: experience in medical field.
SMC 2007: 3457-3463 |
| 4 | | Massimo Buscema,
Paolo Maria Rossini,
Claudio Babiloni,
Enzo Grossi:
The IFAST model, a novel parallel nonlinear EEG analysis technique, distinguishes mild cognitive impairment and Alzheimer's disease patients with high degree of accuracy.
Artificial Intelligence in Medicine 40(2): 127-141 (2007) |
| 2005 |
|---|
| 3 | | Massimo Buscema,
Enzo Grossi,
Marco Intraligi,
N. Garbagna,
A. Andriulli,
M. Breda:
An optimized experimental protocol based on neuro-evolutionary algorithms: Application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment.
Artificial Intelligence in Medicine 34(3): 279-305 (2005) |
| 2004 |
|---|
| 2 | | Massimo Buscema,
Enzo Grossi,
David Snowdon,
Piero Antuono,
Marco Intraligi,
Guido Maurelli,
Rita Savarè:
Artificial neural networks and artificial organisms can predict alzheimer pathology in individual patients only on the basis of cognitive and functional status.
Neuroinformatics 2(4): 399-415 (2004) |
| 2002 |
|---|
| 1 | | M. C. Grassi,
A. M. Caricati,
Marco Intraligi,
Massimo Buscema,
P. Nencini:
Artificial neural network assessment of substitutive pharmacological treatments in hospitalised intravenous drug users.
Artificial Intelligence in Medicine 24(1): 37-49 (2002) |
Data released under the ODC-BY 1.0 license — See also our legal information page